A carregar...
Structural Basis for the Regulation of PPARγ Activity by Imatinib
Imatinib is an effective anticancer drug for the treatment of leukemia. Interestingly, when an FDA-approved drug library was tested for agents that block peroxisome proliferator-activated receptor γ (PPARγ) phosphorylation at Ser245 to evaluate possibilities of antidiabetic drug repositioning, imati...
Na minha lista:
| Publicado no: | Molecules |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6803859/ https://ncbi.nlm.nih.gov/pubmed/31581474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24193562 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|